Globus Medical Inc. (NYSE:GMED), a leading medical device company specializing in musculoskeletal disorders, has been making waves in the healthcare sector with its recent acquisition of Nevro Corp ...

Nevro (NVRO), another stock in the Zacks Medical ... Should You Invest in Globus Medical, Inc. (GMED)? Before you invest in Globus Medical, Inc. (GMED), want to know the best stocks to buy ...

Nevro Corp (NYSE:NVRO), a medical device company specializing in spinal cord stimulation (SCS) technology for chronic pain treatment, has recently undergone significant changes in its market position ...

Globus Medical will acquire Nevro in an all-cash transaction. Both company boards of directors have unanimously approved the ...

Globus Medical started 2025 on a solid note, but a deal for loss-making Nevro creates some discomfort among investors. Read ...

Wall Street expects a year-over-year decline in earnings on lower revenues when Nevro (NVRO) reports results for the quarter ended December 2024. While this widely-known consensus outlook is ...

Shares of GMED opened at $84.04 on Friday. The stock has a market cap of $11.44 billion, a price-to-earnings ratio of 125.44, a P/E/G ratio of 1.68 and a beta of 1.19.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

West Pharmaceutical's overall top line in the fourth quarter of 2024 continues to benefit from revenue growth in its Proprietary Products segment. Brinker International, Business First Bancshares ...